These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6229898

  • 1. The behaviour of various platelet function tests during long-term prostacyclin infusion in patients with peripheral vascular disease.
    Sinzinger H, Horsch AK, Silberbauer K.
    Thromb Haemost; 1983 Dec 30; 50(4):885-7. PubMed ID: 6229898
    [Abstract] [Full Text] [Related]

  • 2. The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass.
    Malpass TW, Amory DW, Harker LA, Ivey TD, Williams DB.
    J Thorac Cardiovasc Surg; 1984 Apr 30; 87(4):550-5. PubMed ID: 6231433
    [Abstract] [Full Text] [Related]

  • 3. Platelet proteins during and after prostacyclin therapy for lower limb ischaemia--suggestion of a rebound platelet activation.
    Blättler W, Furrer K, Schriber K, Kofmehl R, Massini C.
    Vasa; 1981 Apr 30; 10(3):261-3. PubMed ID: 6169225
    [No Abstract] [Full Text] [Related]

  • 4. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374).
    Kappa JR, Cottrell ED, Berkowitz HD, Fisher CA, Sobel M, Ellison N, Addonizio VP.
    J Vasc Surg; 1987 May 30; 5(5):693-701. PubMed ID: 2437338
    [Abstract] [Full Text] [Related]

  • 5. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests.
    Gresele P, Catalano M, Giammarresi C, Volpato R, Termini R, Ciabattoni G, Nenci GG, Davì G.
    Thromb Haemost; 1997 Dec 30; 78(6):1434-7. PubMed ID: 9423790
    [Abstract] [Full Text] [Related]

  • 6. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Dec 30; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 7. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A, Becucci A, Citi S, Cozzolino F, Guidi G, Lombardi V, Vercelli D, Veloci M.
    Haematologica; 1982 Dec 30; 67(6):860-6. PubMed ID: 6186580
    [No Abstract] [Full Text] [Related]

  • 8. Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD).
    Fitscha P, Tiso B, Krais T, Sinzinger H.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Dec 30; 17A():450-4. PubMed ID: 2444079
    [No Abstract] [Full Text] [Related]

  • 9. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J, Christe M, Lämmle B, Marbet GA, Berger W, Duckert F.
    Thromb Haemost; 1984 Dec 29; 52(3):236-9. PubMed ID: 6241750
    [Abstract] [Full Text] [Related]

  • 10. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H.
    Clin Nephrol; 1982 Jan 29; 17(1):24-30. PubMed ID: 6459902
    [Abstract] [Full Text] [Related]

  • 11. [Determination of platelet activation products (platelet factor IV and beta-thromboglobulin) in a group of workers with long-term exposure to carbon disulfide].
    Craveri A, Lanfredini M, Tornaghi G, Frangione A, Milella AM, Ranieri R, Tonali M, Gatti L, Franco G, Moia M.
    G Clin Med; 1980 Nov 29; 61(11):812-21. PubMed ID: 6165639
    [No Abstract] [Full Text] [Related]

  • 12. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW, Savage B, Hanson SR, Slichter SJ, Harker LA.
    J Lab Clin Med; 1984 Jun 29; 103(6):894-904. PubMed ID: 6233383
    [Abstract] [Full Text] [Related]

  • 13. Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?
    Sinzinger H, Silberbauer K, Horsch AK, Gall A.
    Prostaglandins; 1981 Jan 29; 21(1):49-51. PubMed ID: 7010457
    [Abstract] [Full Text] [Related]

  • 14. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA, Bonnar J.
    Thromb Haemost; 1994 Dec 29; 72(6):926-30. PubMed ID: 7740465
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
    Berild D, Hasselbalch H, Knudsen JB.
    Scand J Clin Lab Invest; 1987 Sep 29; 47(5):497-501. PubMed ID: 3477851
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA, Chou TC, Lin KC.
    J Hum Hypertens; 1994 Apr 29; 8(4):273-8. PubMed ID: 8021907
    [Abstract] [Full Text] [Related]

  • 19. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ, Williams SA, Nugent DJ, Harrison P, Segal HC, Syed A, Rothwell PM.
    Thromb Haemost; 2009 Jan 29; 101(1):123-33. PubMed ID: 19132198
    [Abstract] [Full Text] [Related]

  • 20. Platelet activation markers in long-term follow-up of young subjects with acute myocardial infarction.
    Lo Presti R, D'Amico T, Montana M, Canino B, Romano A, Caimi G.
    Clin Hemorheol Microcirc; 2006 Jan 29; 35(4):527-8. PubMed ID: 17148852
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.